title: [Treatment and prevention of conjugation jaundice in newborn infants].
abstract: Risk factors of conjugation jaundice, developing in full-term newborns are listed. They should be taken into account at first neonatal examination of the infant in order to timely prevent marked hyperbilirubinemia. Treatment for conjugation jaundice should be combined and aim to improve hepatic activity and bilirubin lysis and withdrawal from the body.
authors.forename: S K
authors.initials: SK
authors.lastname: Levitskaia
authors.forename: G F
authors.initials: GF
authors.lastname: Elinevskaia
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D005947:Glucose / Q000008:administration & dosage; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D010789:Phototherapy; D012256:Riboflavin / Q000627:therapeutic use; D012996:Solutions
chemical_list: D000900:Anti-Bacterial Agents; D012996:Solutions; D005947:Glucose; D012256:Riboflavin
vernacular_title: Lechenie i profilaktika konïugatsionnoĭ zheltukhi u novorozhdennykh.